Regulation of Candida albicans morphogenesis by fatty acid metabolites

被引:343
作者
Noverr, MC
Huffnagle, GB [1 ]
机构
[1] Univ Michigan, Sch Med, Div Pulm & Crit Care, Dept Internal Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA
关键词
D O I
10.1128/IAI.72.11.6206-6210.2004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Candida albicans is an opportunistic dimorphic fungus that inhabits various host mucosal sites. Conversion from the yeast to the hyphal form has been associated with increased virulence and mucosal invasiveness. C. albicans morphogenesis is regulated by multiple signals and signaling pathways. However, signals that control morphogenesis in vivo are unknown. We investigated the effects of host long chain fatty acids, eicosanoids, and bacterial short chain fatty acids on control of germination. None of the C-18 or C-20 fatty acids tested had an effect on enhancing germ tube formation (arachidonic acid, oleic acid, linolenic acid, or gamma-linolenic acid). Among the different eicosanoids, both prostaglandin E-2 and thromboxane B-2 significantly enhanced serum-induced germination by C. albicans. Addition of antiprostaglandin or antithromboxane antibodies to serum alone inhibited germ tube formation by almost 30%, while control antibody had no effect, indicating that these eicosanoids are major morphogenic factors in the serum. Since these molecules also bind to albumin, this may also explain the hyphal transforming activity in serum that associates with albumin. Interestingly, short chain fatty acids (butyric acid), the product of lactic acid bacteria (LAB), inhibited germination. In addition, LAB culture supernatants as well as live LAB also inhibited C. albicans morphogenesis. Overall, these results indicate that fatty acid metabolites and fatty acid pathways can up-regulate and down-regulate germination in C albicans.
引用
收藏
页码:6206 / 6210
页数:5
相关论文
共 47 条
[1]   A RAPID COLORIMETRIC ASSAY FOR DETERMINATION OF LEUKOCYTE-MEDIATED INHIBITION OF MYCELIAL GROWTH OF CANDIDA-ALBICANS [J].
ABE, S ;
SATOH, T ;
TOKUDA, Y ;
TANSHO, S ;
YAMAGUCHI, H .
MICROBIOLOGY AND IMMUNOLOGY, 1994, 38 (05) :385-388
[2]   Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans [J].
Alem, MAS ;
Douglas, LJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) :41-47
[3]   PHYSIOLOGIC VARIABLES AFFECTING THROMBOXANE-B2 PRODUCTION IN HUMAN WHOLE-BLOOD [J].
ALESSANDRINI, P ;
AVOGARO, P ;
BON, GB ;
PATRIGNANI, P ;
PATRONO, C .
THROMBOSIS RESEARCH, 1985, 37 (01) :1-8
[4]  
ANDLEIGH H S, 1964, Mycopathol Mycol Appl, V23, P81, DOI 10.1007/BF02049262
[5]   Role of dietary fiber and short-chain fatty acids in the colon [J].
Andoh, A ;
Tsujikawa, T ;
Fujiyama, Y .
CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (04) :347-358
[6]   FACTORS PRESENT IN SERUM AND SEMINAL PLASMA WHICH PROMOTE GERM-TUBE FORMATION AND MYCELIAL GROWTH OF CANDIDA-ALBICANS [J].
BARLOW, AJE ;
ALDERSLEY, T ;
CHATTAWAY, FW .
JOURNAL OF GENERAL MICROBIOLOGY, 1974, 82 (JUN) :261-272
[7]  
BETZ M, 1991, J IMMUNOL, V146, P108
[8]  
Birkbeck J, 1999, MEDICAL IMPORTANCE OF THE NORMAL MICROFLORA, P262
[9]  
Blaut Michael, 2002, European Journal of Nutrition, V41, P11
[10]   n-butyrate downregulates the stimulatory function of peripheral blood-derived antigen-presenting cells: a potential mechanism for modulating T-cell responses by short-chain fatty acids [J].
Bohmig, GA ;
Krieger, PM ;
Saemann, MD ;
Wenhardt, C ;
Pohanka, E ;
Zlabinger, GJ .
IMMUNOLOGY, 1997, 92 (02) :234-243